The global cell-free fetal dna testing industry size is expected to have a CAGR of 10.9%. By 2023, the market is anticipated to be worth US$ 1,466.3 million, and by 2033, it’s anticipated to be worth US$ 4,124.7 million. The cell-free fetal dna testing market refers to the market for non-invasive prenatal tests (NIPT) that …